援助如何运作
通过无与伦比的全方位服务便利性，简化患者的专业药房体验
-
1. 检查您的保险范围/福利验证
我们的专业出纳员团队会找到最佳的保险途径，以最大程度地减少自付费用。
-
2. 将处方转移到 AmeriPharma®
我们与您之前的药房或处方人员合作来处理您的处方，使过渡变得快速而简单。
-
3. 事先授权
我们的专家团队将在 24 至 72 小时内获得您保险公司的批准。
-
4. 共付额援助和经济援助
我们确保患者获得经济援助，并降低共付额、自付费用和高额免赔额。迄今为止，AmeriPharma® 专科护理已为患者争取到 1TP4.4755 亿美元的经济援助。
-
5.护理协调
AmeriPharma® 在安排和协调我们的专业护士为您进行家庭输液时，会将您的日程安排和家庭环境放在首位。
-
6. 交付协调
药品始终严格遵守运输的具体要求。次日或隔夜冷链配送将根据您的时间安排进行协调。
What Is Fasenra?
Fasenra is an injectable prescription drug with the active substance, benralizumab. It is approved for treating eosinophilic asthma in adolescents (children aged 12 years or over) and adults. In people whose asthma is not controlled by their existing asthma drugs, Fasenra is used as an add-on therapy.
It is frequently used with other asthma medications (inhaled corticosteroids) to treat asthma symptoms, including wheezing and shortness of breath, and to avoid asthma episodes (flare-ups).
Fasenra can only be obtained via doctor’s prescription and is available in solution form for injection purposes.
Is There a Generic for Fasenra?
There is no biosimilar (generic) of Fasenra. It is only available in brand form, making the medication expensive, even with insurance.
What Is Fasenra Used To Treat?
Fasenra has only been approved to treat eosinophilic asthma; it has not been approved to treat other eosinophil-related illnesses or severe acute asthma, such as acute bronchospasm or status asthmaticus.
Patients with eosinophilic asthma (EA), an uncommon but severe form of asthma, frequently have a disproportionately high quantity of eosinophils in their blood and phlegm (thick mucus) in their lungs. Eosinophils are the kind of white blood cell that ordinarily fights off infection-causing germs.
In the case of eosinophilic asthma (EA), however, the activation of too many eosinophils by typical asthma triggers produces inflammation and swelling in the respiratory tract, resulting in difficulty breathing and asthma attacks.
共付额和经济援助
AmeriPharma™ 专业药房减轻患者及其家人的经济负担
-
先进的软件可以定位资金来源，为您匹配高额的基金会项目
-
我们的一位共付额援助专家将协助您完成申请流程
-
自动更新信息将发送给您和您的医生，告知您资金状况
剂量信息
The recommended dose of Fasenra for adults and children 12 years or older is 30 mg/ml once every 4 weeks for the first three doses and then once every 8 weeks thereafter.
Fasenra Dosage Form and Strength
Fasenra comes in one strength: 30 mg/ml of a colorless liquid solution. It is available in two forms:
- Single-dose, prefilled syringes designed for healthcare professionals
- Single-dose, prefilled autoinjector pens designed for patients or caregivers
Each single-dose prefilled syringe delivers 1 ml containing 30 mg of benralizumab into the body.
How Is Fasenra Given?
The 30 mg/ml dose of Fasenra is injected under the skin beneath the fat layer (subcutaneous).
The Fasenra prefilled injection is usually given by a healthcare provider under the skin of the upper arms, thighs, and abdomen (belly) areas.
After proper training, patients and their caregivers can inject Fasenra injection.
接受保险
我们接受 Medicare、跨州 Medicaid、Medi-Cal、Blue Shield 以及大多数私人保险。请致电我们，了解更多您的保险信息。
Chinese 
English 
Spanish 
Vietnamese